Does RIBOCICLIB Cause Secretion discharge? 49 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Secretion discharge have been filed in association with RIBOCICLIB (KISQALI). This represents 0.2% of all adverse event reports for RIBOCICLIB.
49
Reports of Secretion discharge with RIBOCICLIB
0.2%
of all RIBOCICLIB reports
1
Deaths
17
Hospitalizations
How Dangerous Is Secretion discharge From RIBOCICLIB?
Of the 49 reports, 1 (2.0%) resulted in death, 17 (34.7%) required hospitalization, and 4 (8.2%) were considered life-threatening.
Is Secretion discharge Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Secretion discharge?
ADALIMUMAB (685)
DUPILUMAB (626)
ALBUTEROL (520)
OMALIZUMAB (514)
ETANERCEPT (487)
METHOTREXATE (387)
MEPOLIZUMAB (359)
BUDESONIDE\FORMOTEROL (339)
PREDNISONE (316)
SECUKINUMAB (307)
Which RIBOCICLIB Alternatives Have Lower Secretion discharge Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN